Faculty

Institution

Unit

Venue

Department Of Investigational Cancer Therapeutics

The University of Texas MD Anderson Cancer Center

Notable Concepts

jama oncology

#67

5.238

122

future medicinal chemistry

#77

1.340

metronomic therapy

#11

2.247

drug trials

#30

3.944

tumor heterogeneity

#44

7.036

105

immune checkpoint inhibitors

#53

10.838

237

Research Keyword Cloud

Time:

All

You can click a keyword to filter the displayed items

cancer research clinical trials clinical research oncology medicinal research cancer care cancer imaging cancer treatment cancer biology cancer management therapeutic targets breast cancer tumor biology cancer immunotherapy surgical oncology thoracic oncology pharmacotherapy oncogenes molecular cancer cellular therapy leukemia anti-cancer agents tumor targeting immune checkpoint inhibitors advanced solid tumors cancer discovery enzyme inhibition cancer cells molecular diagnostics experimental medicine novel therapies therapeutic efficacy tumor heterogeneity cancer genetics cancer genomics gynecologic oncology drug targeting solid tumors drug trials colorectal cancer tumor suppressors advanced cancers gastrointestinal oncology breast oncology advanced cancer cohort studies advanced malignancies clinical immunology cancer immunosurveillance liver cancer metronomic therapy genitourinary cancers clinical radiation oncology metastatic solid tumors phase 1 prognosis lymphoid neoplasia precision medicine hematological malignancies clinical evidence clinical mycology radiation therapy next-generation sequencing cancer patients hyperprogressive disease chronic lymphocytic leukemia acute myeloid leukemia outcome analyses intensive care unit immune checkpoint blockade advanced solid malignancies

Graph settings

Graph showing relationships of top 10 results with most publications.

Drag nodes to adjust view
Interactive network
Click node/link for info

Scholars

Notable Scholarly Works

Collaborators

David Hong

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

pharmacology

medicinal research

radiation oncology

clinical research

cancer care

medicine

tumor biology

cancer immunotherapy

cancer biology

oncogenes

tumor targeting

clinical trials

cancer discovery

surgical oncology

immunology

pharmacotherapy

anti-cancer agents

therapeutic targets

molecular cancer

urology

molecular biology

immunotherapy

cellular therapy

advanced solid tumors

cancer management

cancer genetics

thoracic oncology

cancer genomics

lung cancer

novel therapies

cancer cells

enzyme inhibition

leukemia

therapeutic efficacy

breast cancer

gynecologic oncology

tumor microenvironment

metastasis

cancer imaging

vascular biology

immune checkpoint inhibitors

advanced cancers

colorectal cancer

advanced cancer

tumor heterogeneity

drug discovery

clinical investigation

tumor suppressors

clinical radiation oncology

solid tumors

gastrointestinal oncology

molecular diagnostics

experimental medicine

cohort studies

medical mycology

drug trials

jama oncology

clinical evidence

clinical mycology

radiation therapy

advanced malignancies

Funda Meric-Bernstam

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

radiation oncology

pharmacology

oncogenes

medicinal research

molecular cancer

breast cancer

cancer care

cancer biology

tumor biology

pathology

clinical research

medicine

cancer immunotherapy

cancer discovery

cancer genetics

cancer cells

cancer genomics

therapeutic targets

tumor targeting

anti-cancer agents

breast oncology

genetics

immunology

cell biology

molecular biology

surgical oncology

metastasis

pharmacotherapy

molecular diagnostics

clinical trials

immunotherapy

cancer management

cellular therapy

genomics

drug discovery

gynecologic oncology

cancer imaging

colorectal cancer

advanced solid tumors

enzyme inhibition

drug targeting

novel therapies

thoracic oncology

leukemia

tumor heterogeneity

tumor microenvironment

lung cancer

jama oncology

genome biology

immune checkpoint inhibitors

malignant disease

solid tumors

advanced cancers

genitourinary cancers

next-generation sequencing

gastrointestinal oncology

vascular biology

experimental medicine

medical mycology

tumor suppressors

therapeutic efficacy

phase 1

Sarina Piha-Paul

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

pharmacology

medicinal research

radiation oncology

cancer care

clinical research

medicine

cancer immunotherapy

oncogenes

pharmacotherapy

immunology

tumor biology

anti-cancer agents

molecular cancer

tumor targeting

clinical trials

cancer discovery

urology

cancer biology

therapeutic targets

immunotherapy

surgical oncology

advanced solid tumors

pathology

cancer management

breast cancer

cancer genetics

cellular therapy

novel therapies

gynecologic oncology

cancer genomics

cancer cells

immune checkpoint inhibitors

metastasis

thoracic oncology

leukemia

advanced cancers

advanced cancer

tumor microenvironment

lung cancer

enzyme inhibition

vascular biology

tumor heterogeneity

therapeutic efficacy

molecular diagnostics

medical mycology

jama oncology

drug discovery

prostate cancer

cancer imaging

drug trials

experimental medicine

breast oncology

carcinogenesis

cohort studies

drug targeting

colorectal cancer

clinical investigation

gastrointestinal oncology

genitourinary cancers

tumor suppressors

solid tumors

Timothy Yap

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

pharmacology

cancer treatment

medicinal research

radiation oncology

clinical research

medicine

cancer care

therapeutic targets

pharmacotherapy

oncogenes

tumor biology

anti-cancer agents

molecular cancer

cancer immunotherapy

cancer discovery

cancer biology

immunology

tumor targeting

clinical trials

cancer genomics

enzyme inhibition

advanced solid tumors

immunotherapy

cancer cells

novel therapies

cancer genetics

cancer management

drug discovery

molecular diagnostics

leukemia

gynecologic oncology

cellular therapy

surgical oncology

breast cancer

cancer imaging

ovarian cancer

prostate cancer

experimental medicine

drug targeting

immune checkpoint inhibitors

tumor heterogeneity

thoracic oncology

therapeutic efficacy

solid tumors

Apostolia Tsimberidou

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

pharmacology

medicine

radiation oncology

medicinal research

cancer care

clinical research

tumor biology

cancer immunotherapy

immunology

pharmacotherapy

oncogenes

cancer discovery

clinical trials

therapeutic targets

leukemia

tumor targeting

cancer biology

molecular cancer

hematology

anti-cancer agents

pathology

cancer management

surgical oncology

urology

immunotherapy

hematological malignancies

metastasis

cancer genomics

cellular therapy

breast cancer

novel therapies

cancer genetics

cancer cells

advanced solid tumors

vascular biology

gynecologic oncology

advanced cancers

advanced cancer

enzyme inhibition

thoracic oncology

lymphoid neoplasia

tumor microenvironment

outcomes research

molecular diagnostics

immune checkpoint inhibitors

tumor heterogeneity

personalized medicine

gliomas

cancer imaging

colorectal cancer

jama oncology

lung cancer

breast oncology

precision medicine

drug trials

therapeutic efficacy

tumor suppressors

metronomic therapy

chronic lymphocytic leukemia

experimental medicine

liver cancer

gastrointestinal oncology

acute myeloid leukemia

solid tumors

advanced malignancies

metastatic solid tumors

Aung Naing

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

pharmacology

medicinal research

cancer immunotherapy

radiation oncology

cancer care

immunology

medicine

clinical research

immunotherapy

oncogenes

tumor biology

pharmacotherapy

clinical trials

anti-cancer agents

therapeutic targets

cancer discovery

molecular cancer

tumor targeting

immune checkpoint inhibitors

cellular therapy

urology

pathology

cancer biology

surgical oncology

cancer management

cancer cells

advanced solid tumors

gynecologic oncology

thoracic oncology

novel therapies

metastasis

leukemia

cancer genetics

lung cancer

experimental medicine

jama oncology

advanced cancers

therapeutic efficacy

breast cancer

advanced cancer

clinical immunology

tumor microenvironment

cancer genomics

enzyme inhibition

vascular biology

outcomes research

cancer immunosurveillance

clinical investigation

tumor heterogeneity

drug trials

drug discovery

colorectal cancer

tumor suppressors

cancer imaging

metronomic therapy

cohort studies

advanced malignancies

medical mycology

molecular diagnostics

drug targeting

gastrointestinal oncology

solid tumors

Jordi Rodon Ahnert

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

pharmacology

cancer treatment

radiation oncology

medicinal research

medicine

cancer immunotherapy

cancer care

oncogenes

tumor biology

cancer biology

molecular cancer

clinical research

therapeutic targets

anti-cancer agents

tumor targeting

pharmacotherapy

cancer genomics

clinical trials

cancer discovery

cancer genetics

advanced solid tumors

breast cancer

cancer cells

immunotherapy

enzyme inhibition

cellular therapy

drug discovery

metastasis

cancer management

cancer imaging

molecular diagnostics

drug targeting

tumor microenvironment

leukemia

brain tumor research

novel therapies

surgical oncology

experimental medicine

therapeutic efficacy

drug trials

tumor heterogeneity

thoracic oncology

breast oncology

immune checkpoint inhibitors

Stephane Champiat

Institution

The University of Texas MD Anderson Cancer Center

oncology

immunology

cancer immunotherapy

immunotherapy

cancer research

medicine

pharmacology

medicinal research

cancer care

cancer treatment

radiation oncology

anti-cancer agents

immune checkpoint inhibitors

cellular therapy

pharmacotherapy

thoracic oncology

oncogenes

clinical research

tumor biology

tumor targeting

lung cancer

cancer biology

clinical immunology

cancer imaging

clinical trials

therapeutic targets

experimental medicine

drug targeting

medical mycology

cancer immunosurveillance

molecular cancer

leukemia

cancer management

prognosis

hyperprogressive disease

advanced solid tumors

cancer patients

Siqing Fu

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

pharmacology

medicinal research

radiation oncology

cancer care

medicine

clinical research

tumor biology

oncogenes

cancer immunotherapy

cancer discovery

tumor targeting

clinical trials

molecular cancer

immunology

pharmacotherapy

cancer biology

surgical oncology

therapeutic targets

urology

cancer management

anti-cancer agents

gynecologic oncology

molecular biology

cancer cells

cancer genetics

immunotherapy

novel therapies

advanced solid tumors

cellular therapy

metastasis

thoracic oncology

advanced cancers

advanced cancer

breast cancer

leukemia

cancer genomics

immune checkpoint inhibitors

gynecologic cancers

enzyme inhibition

vascular biology

tumor microenvironment

ovarian cancer

lung cancer

tumor heterogeneity

tumor suppressors

gliomas

clinical investigation

therapeutic efficacy

cancer imaging

colorectal cancer

molecular diagnostics

jama oncology

drug trials

liver cancer

gastrointestinal oncology

drug targeting

cohort studies

advanced malignancies

solid tumors

Ecaterina Dumbrava

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer treatment

cancer research

pharmacology

radiation oncology

medicinal research

cancer immunotherapy

cancer care

oncogenes

medicine

immunology

molecular cancer

clinical research

tumor biology

immunotherapy

pharmacotherapy

cancer cells

therapeutic targets

tumor targeting

cellular therapy

anti-cancer agents

cancer discovery

cancer biology

breast cancer

clinical trials

immune checkpoint inhibitors

advanced solid tumors

cell biology

pathology

metastasis

urology

cancer genetics

cancer management

cancer genomics

gynecologic oncology

breast oncology

novel therapies

tumor microenvironment

surgical oncology

experimental medicine

tumor heterogeneity

enzyme inhibition

tumor suppressors

thoracic oncology

jama oncology

therapeutic efficacy

solid tumors

lung cancer

leukemia

vascular biology

molecular diagnostics

prostate cancer

colorectal cancer

drug discovery

cancer imaging

cancer immunosurveillance

drug targeting

oncogenic agent

clinical investigation

cancer letter

brain tumor research

clinical immunology

drug trials

clinical radiation oncology

metastatic solid tumors

immune checkpoint blockade

advanced cancers

advanced solid malignancies

phase 1

Diane Barber

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer care

medicine

cancer research

surgical oncology

critical care

cancer treatment

cancer management

outcome analyses

intensive care unit

pharmacology

radiation oncology

emergency medicine

epidemiology

breast cancer

hepatology

metastasis

telehealth

digital health

clinical trials

clinical research

outcomes research

medicinal research

cancer imaging

health technology

medical internet research

symptom management

intensive care

clinical investigation

intensive care nursing

liver cancer

cancer biology

telecare

patient-reported outcomes

clinical implementation

clinical evaluation

case studies

clinical endpoint

Traci Pitre

Institution

The University of Texas MD Anderson Cancer Center

Hayley Harrison

Institution

The University of Texas MD Anderson Cancer Center

Tin-Yun Tang

Institution

The University of Texas MD Anderson Cancer Center

Melissa Ford

Institution

The University of Texas MD Anderson Cancer Center

Yagut Retondo

Institution

The University of Texas MD Anderson Cancer Center

Jubi Nair

Institution

The University of Texas MD Anderson Cancer Center

1
30 / page

Department Of Investigational Cancer Therapeutics

The University of Texas MD Anderson Cancer Center

Notable Concepts

jama oncology

#67

5.238

122

future medicinal chemistry

#77

1.340

metronomic therapy

#11

2.247

drug trials

#30

3.944

tumor heterogeneity

#44

7.036

105

immune checkpoint inhibitors

#53

10.838

237

Research Keyword Cloud

Time:

All

You can click a keyword to filter the displayed items

Graph settings

Graph showing relationships of top 10 results with most publications.

Drag nodes to adjust view
Interactive network
Click node/link for info

Scholars

Notable Scholarly Works

Collaborators

David Hong

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

pharmacology

medicinal research

radiation oncology

clinical research

cancer care

medicine

tumor biology

cancer immunotherapy

cancer biology

oncogenes

tumor targeting

clinical trials

cancer discovery

surgical oncology

immunology

pharmacotherapy

anti-cancer agents

therapeutic targets

molecular cancer

urology

molecular biology

immunotherapy

cellular therapy

advanced solid tumors

cancer management

cancer genetics

thoracic oncology

cancer genomics

lung cancer

novel therapies

cancer cells

enzyme inhibition

leukemia

therapeutic efficacy

breast cancer

gynecologic oncology

tumor microenvironment

metastasis

cancer imaging

vascular biology

immune checkpoint inhibitors

advanced cancers

colorectal cancer

advanced cancer

tumor heterogeneity

drug discovery

clinical investigation

tumor suppressors

clinical radiation oncology

solid tumors

gastrointestinal oncology

molecular diagnostics

experimental medicine

cohort studies

medical mycology

drug trials

jama oncology

clinical evidence

clinical mycology

radiation therapy

advanced malignancies

Funda Meric-Bernstam

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

radiation oncology

pharmacology

oncogenes

medicinal research

molecular cancer

breast cancer

cancer care

cancer biology

tumor biology

pathology

clinical research

medicine

cancer immunotherapy

cancer discovery

cancer genetics

cancer cells

cancer genomics

therapeutic targets

tumor targeting

anti-cancer agents

breast oncology

genetics

immunology

cell biology

molecular biology

surgical oncology

metastasis

pharmacotherapy

molecular diagnostics

clinical trials

immunotherapy

cancer management

cellular therapy

genomics

drug discovery

gynecologic oncology

cancer imaging

colorectal cancer

advanced solid tumors

enzyme inhibition

drug targeting

novel therapies

thoracic oncology

leukemia

tumor heterogeneity

tumor microenvironment

lung cancer

jama oncology

genome biology

immune checkpoint inhibitors

malignant disease

solid tumors

advanced cancers

genitourinary cancers

next-generation sequencing

gastrointestinal oncology

vascular biology

experimental medicine

medical mycology

tumor suppressors

therapeutic efficacy

phase 1

Sarina Piha-Paul

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

pharmacology

medicinal research

radiation oncology

cancer care

clinical research

medicine

cancer immunotherapy

oncogenes

pharmacotherapy

immunology

tumor biology

anti-cancer agents

molecular cancer

tumor targeting

clinical trials

cancer discovery

urology

cancer biology

therapeutic targets

immunotherapy

surgical oncology

advanced solid tumors

pathology

cancer management

breast cancer

cancer genetics

cellular therapy

novel therapies

gynecologic oncology

cancer genomics

cancer cells

immune checkpoint inhibitors

metastasis

thoracic oncology

leukemia

advanced cancers

advanced cancer

tumor microenvironment

lung cancer

enzyme inhibition

vascular biology

tumor heterogeneity

therapeutic efficacy

molecular diagnostics

medical mycology

jama oncology

drug discovery

prostate cancer

cancer imaging

drug trials

experimental medicine

breast oncology

carcinogenesis

cohort studies

drug targeting

colorectal cancer

clinical investigation

gastrointestinal oncology

genitourinary cancers

tumor suppressors

solid tumors

Timothy Yap

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

pharmacology

cancer treatment

medicinal research

radiation oncology

clinical research

medicine

cancer care

therapeutic targets

pharmacotherapy

oncogenes

tumor biology

anti-cancer agents

molecular cancer

cancer immunotherapy

cancer discovery

cancer biology

immunology

tumor targeting

clinical trials

cancer genomics

enzyme inhibition

advanced solid tumors

immunotherapy

cancer cells

novel therapies

cancer genetics

cancer management

drug discovery

molecular diagnostics

leukemia

gynecologic oncology

cellular therapy

surgical oncology

breast cancer

cancer imaging

ovarian cancer

prostate cancer

experimental medicine

drug targeting

immune checkpoint inhibitors

tumor heterogeneity

thoracic oncology

therapeutic efficacy

solid tumors

Apostolia Tsimberidou

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

pharmacology

medicine

radiation oncology

medicinal research

cancer care

clinical research

tumor biology

cancer immunotherapy

immunology

pharmacotherapy

oncogenes

cancer discovery

clinical trials

therapeutic targets

leukemia

tumor targeting

cancer biology

molecular cancer

hematology

anti-cancer agents

pathology

cancer management

surgical oncology

urology

immunotherapy

hematological malignancies

metastasis

cancer genomics

cellular therapy

breast cancer

novel therapies

cancer genetics

cancer cells

advanced solid tumors

vascular biology

gynecologic oncology

advanced cancers

advanced cancer

enzyme inhibition

thoracic oncology

lymphoid neoplasia

tumor microenvironment

outcomes research

molecular diagnostics

immune checkpoint inhibitors

tumor heterogeneity

personalized medicine

gliomas

cancer imaging

colorectal cancer

jama oncology

lung cancer

breast oncology

precision medicine

drug trials

therapeutic efficacy

tumor suppressors

metronomic therapy

chronic lymphocytic leukemia

experimental medicine

liver cancer

gastrointestinal oncology

acute myeloid leukemia

solid tumors

advanced malignancies

metastatic solid tumors

Aung Naing

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

pharmacology

medicinal research

cancer immunotherapy

radiation oncology

cancer care

immunology

medicine

clinical research

immunotherapy

oncogenes

tumor biology

pharmacotherapy

clinical trials

anti-cancer agents

therapeutic targets

cancer discovery

molecular cancer

tumor targeting

immune checkpoint inhibitors

cellular therapy

urology

pathology

cancer biology

surgical oncology

cancer management

cancer cells

advanced solid tumors

gynecologic oncology

thoracic oncology

novel therapies

metastasis

leukemia

cancer genetics

lung cancer

experimental medicine

jama oncology

advanced cancers

therapeutic efficacy

breast cancer

advanced cancer

clinical immunology

tumor microenvironment

cancer genomics

enzyme inhibition

vascular biology

outcomes research

cancer immunosurveillance

clinical investigation

tumor heterogeneity

drug trials

drug discovery

colorectal cancer

tumor suppressors

cancer imaging

metronomic therapy

cohort studies

advanced malignancies

medical mycology

molecular diagnostics

drug targeting

gastrointestinal oncology

solid tumors

Jordi Rodon Ahnert

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

pharmacology

cancer treatment

radiation oncology

medicinal research

medicine

cancer immunotherapy

cancer care

oncogenes

tumor biology

cancer biology

molecular cancer

clinical research

therapeutic targets

anti-cancer agents

tumor targeting

pharmacotherapy

cancer genomics

clinical trials

cancer discovery

cancer genetics

advanced solid tumors

breast cancer

cancer cells

immunotherapy

enzyme inhibition

cellular therapy

drug discovery

metastasis

cancer management

cancer imaging

molecular diagnostics

drug targeting

tumor microenvironment

leukemia

brain tumor research

novel therapies

surgical oncology

experimental medicine

therapeutic efficacy

drug trials

tumor heterogeneity

thoracic oncology

breast oncology

immune checkpoint inhibitors

Stephane Champiat

Institution

The University of Texas MD Anderson Cancer Center

oncology

immunology

cancer immunotherapy

immunotherapy

cancer research

medicine

pharmacology

medicinal research

cancer care

cancer treatment

radiation oncology

anti-cancer agents

immune checkpoint inhibitors

cellular therapy

pharmacotherapy

thoracic oncology

oncogenes

clinical research

tumor biology

tumor targeting

lung cancer

cancer biology

clinical immunology

cancer imaging

clinical trials

therapeutic targets

experimental medicine

drug targeting

medical mycology

cancer immunosurveillance

molecular cancer

leukemia

cancer management

prognosis

hyperprogressive disease

advanced solid tumors

cancer patients

Siqing Fu

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer research

cancer treatment

pharmacology

medicinal research

radiation oncology

cancer care

medicine

clinical research

tumor biology

oncogenes

cancer immunotherapy

cancer discovery

tumor targeting

clinical trials

molecular cancer

immunology

pharmacotherapy

cancer biology

surgical oncology

therapeutic targets

urology

cancer management

anti-cancer agents

gynecologic oncology

molecular biology

cancer cells

cancer genetics

immunotherapy

novel therapies

advanced solid tumors

cellular therapy

metastasis

thoracic oncology

advanced cancers

advanced cancer

breast cancer

leukemia

cancer genomics

immune checkpoint inhibitors

gynecologic cancers

enzyme inhibition

vascular biology

tumor microenvironment

ovarian cancer

lung cancer

tumor heterogeneity

tumor suppressors

gliomas

clinical investigation

therapeutic efficacy

cancer imaging

colorectal cancer

molecular diagnostics

jama oncology

drug trials

liver cancer

gastrointestinal oncology

drug targeting

cohort studies

advanced malignancies

solid tumors

Ecaterina Dumbrava

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer treatment

cancer research

pharmacology

radiation oncology

medicinal research

cancer immunotherapy

cancer care

oncogenes

medicine

immunology

molecular cancer

clinical research

tumor biology

immunotherapy

pharmacotherapy

cancer cells

therapeutic targets

tumor targeting

cellular therapy

anti-cancer agents

cancer discovery

cancer biology

breast cancer

clinical trials

immune checkpoint inhibitors

advanced solid tumors

cell biology

pathology

metastasis

urology

cancer genetics

cancer management

cancer genomics

gynecologic oncology

breast oncology

novel therapies

tumor microenvironment

surgical oncology

experimental medicine

tumor heterogeneity

enzyme inhibition

tumor suppressors

thoracic oncology

jama oncology

therapeutic efficacy

solid tumors

lung cancer

leukemia

vascular biology

molecular diagnostics

prostate cancer

colorectal cancer

drug discovery

cancer imaging

cancer immunosurveillance

drug targeting

oncogenic agent

clinical investigation

cancer letter

brain tumor research

clinical immunology

drug trials

clinical radiation oncology

metastatic solid tumors

immune checkpoint blockade

advanced cancers

advanced solid malignancies

phase 1

Diane Barber

Institution

The University of Texas MD Anderson Cancer Center

oncology

cancer care

medicine

cancer research

surgical oncology

critical care

cancer treatment

cancer management

outcome analyses

intensive care unit

pharmacology

radiation oncology

emergency medicine

epidemiology

breast cancer

hepatology

metastasis

telehealth

digital health

clinical trials

clinical research

outcomes research

medicinal research

cancer imaging

health technology

medical internet research

symptom management

intensive care

clinical investigation

intensive care nursing

liver cancer

cancer biology

telecare

patient-reported outcomes

clinical implementation

clinical evaluation

case studies

clinical endpoint

Traci Pitre

Institution

The University of Texas MD Anderson Cancer Center

Hayley Harrison

Institution

The University of Texas MD Anderson Cancer Center

Tin-Yun Tang

Institution

The University of Texas MD Anderson Cancer Center

Melissa Ford

Institution

The University of Texas MD Anderson Cancer Center

Yagut Retondo

Institution

The University of Texas MD Anderson Cancer Center

Jubi Nair

Institution

The University of Texas MD Anderson Cancer Center

1
30 / page

Department Of Investigational Cancer Therapeutics

Notable Concepts

Research Keyword Cloud

Collaborator Network

Department Of Investigational Cancer Therapeutics

Notable Concepts

Research Keyword Cloud

Collaborator Network